Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system

Vaccine

Volumn 28, Issue 4, 2010, Pages 989-995

  Dempsey, Amanda ^a   Cohn, Lisa ^a   Dalton, Vanessa ^a   Ruffin, Mack ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Adolescent; Human papillomavirus; Vaccine

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FAMILY MEDICINE; FEMALE; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; HUMAN PAPILLOMAVIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION; VIRUS INFECTION;

ADOLESCENT; AGE FACTORS; CHILD; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; MEDICINE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SOCIOECONOMIC FACTORS; UNITED STATES; UNIVERSITIES; VACCINATION;

EID: 73949099729     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.10.133     Document Type: Article

References (22)

1. U.S. Food and Drug Administration. Product Approval Information-Licensing Action, Gardasil. 2006 [cited August 1, 2006]; Available from: http://www.fda.gov/cber/products/hpvmer060806qa.htm.
2. Winer R.L., Feng Q., Hughes J.P., O'Reilly S., Kiviat N.B., and Koutsky L.A. Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis 197 January (2) (2008) 279-282
3. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., and Unger E.R. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56 March (RR-2) (2007) 1-24
4. Centers for Disease Control and Prevention. Vaccination coverage among adolescents aged 13-17 years-United States, 2007. Morb Mortal Wkly Rep 57 October (40) (2008) 1100-1103
5. Chao C., Slezak J.M., Coleman K.J., and Jacobsen S.J. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health 99 June (6) (2009) 1137-1142
6. Neubrand T.P., Radecki Breitkopf C., Rupp R., Brieitkopf D., and Rosenthal S.L. Factors associated with completion of the human papillomavirus vaccine series. Clin Pediatr (PL) (2009) [Epub May 29]
7. Kahn J.A., Rosenthal S.L., Jin Y., Huang B., Namakydoust A., and Zimet G.D. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol 111 May (5) (2008) 1103-1110
8. Rosenthal S.L., Rupp R., Zimet G.D., Meza H.M., Loza M.L., Short M.B., et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health 43 September (3) (2008) 239-245
9. American Academy of Pediatrics Committee on Infectious Diseases. Prevention of human papillomavirus infection: provisional recommendations for immunization of females with quadrivalent human papillomavirus vaccine. Pediatrics 120 3 (2007) 666-668
10. Dempsey A.F., and Davis M.M. Overcoming barriers to adherence to HPV vaccination recommendations. Am J Manage Care 12 December (17 Suppl.) (2006) S484-S491
11. Garner E.I. Cervical cancer: disparities in screening, treatment, and survival. Cancer Epidemiol Biomarkers Prev 12 March (3) (2003) 242s-247s
12. Wang S.S., Sherman M.E., Hildesheim A., Lacey Jr. J.V., and Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 100 March (5) (2004) 1035-1044
13. Kim J.J., and Goldie S.J. Health and economic implications of HPV vaccination in the United States. N Engl J Med 359 August (8) (2008) 821-832
14. Lee G.M., Lorick S.A., Pfoh E., Kleinman K., and Fishbein D. Adolescent immunizations: missed opportunities for prevention. Pediatrics 122 October (4) (2008) 711-717
15. Halpern-Felsher B.L., Ozer E.M., Millstein S.G., Wibbelsman C.J., Fuster C.D., Elster A.B., et al. Preventive services in a health maintenance organization: how well do pediatricians screen and educate adolescent patients?. Arch Pediatr Adolesc Med 154 February (2) (2000) 173-179
16. Kottke T.E., Solberg L.I., Brekke M.L., Cabrera A., and Marquez M.A. Delivery rates for preventive services in 44 midwestern clinics. Mayo Clin Proc 72 June (6) (1997) 515-523
17. Schaffer S.J., Humiston S.G., Shone L.P., Averhoff F.M., and Szilagyi P.G. Adolescent immunization practices: a national survey of US physicians. Arch Pediatr Adolesc Med 155 May (5) (2001) 566-571
18. Gonik B., Fasano N., and Foster S. The obstetrician-gynecologist's role in adult immunization. Am J Obstet Gynecol 187 October (4) (2002) 984-988
19. Briss P.A., Rodewald L.E., Hinman A.R., Shefer A.M., Strikas R.A., Bernier R.R., et al. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med 18 January (1 Suppl.) (2000) 97-140
20. Rand C.M., Shone L.P., Albertin C., Auinger P., Klein J.D., and Szilagyi P.G. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med 161 March (3) (2007) 252-259
21. Newacheck P.W., Park M.J., Brindis C.D., Biehl M., and Irwin Jr. C.E. Trends in private and public health insurance for adolescents. JAMA 291 March (10) (2004) 1231-1237
22. HEDIS 2002 Guidelines. 2002 [cited November 4th, 2008]; Available from: http://www.ncqa.org/Programs/HEDIS.